All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Repetitive transcranial magnetic stimulation (rTMS) for schizophrenia patients treated with clozapine

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023752%3A_____%2F21%3A43920198" target="_blank" >RIV/00023752:_____/21:43920198 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11120/21:43920030

  • Result on the web

    <a href="https://www.tandfonline.com/doi/full/10.1080/15622975.2020.1733080" target="_blank" >https://www.tandfonline.com/doi/full/10.1080/15622975.2020.1733080</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1080/15622975.2020.1733080" target="_blank" >10.1080/15622975.2020.1733080</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Repetitive transcranial magnetic stimulation (rTMS) for schizophrenia patients treated with clozapine

  • Original language description

    Objectives: Biological strategies to improve treatment efficacy in clozapine-treated patients are urgently needed. Repetitive transcranial magnetic stimulation (rTMS) merits consideration as intervention for patients with persistent auditory hallucinations (AH) or negative symptoms (NS) not responding sufficiently to clozapine treatment. Methods: Data from 10 international RCTs of rTMS for patients being treated with clozapine were pooled. Two levels of symptomatic response were defined: improvement of ≥20% and ≥50% on study-specific primary endpoint scales. Changes in the positive and negative syndrome scale (PANSS) from baseline to endpoint assessment were also analysed. Results: Analyses of 131 patients did not reveal a significant difference for ≥20% and ≥50% response thresholds for improvement of AH, negative or total symptoms between active and sham rTMS groups. The number needed to treat (NNT) for an improvement in persistent AH was nine following active rTMS. PANSS scores did not improve significantly from baseline to endpoint between active and sham groups in studies investigating NS and AH. Conclusions: rTMS as a treatment for persistent symptoms in clozapine-treated patients did not show a beneficial effect of active compared to sham treatment. For AH, the size of the NNTs indicates a possible beneficial effect of rTMS.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30215 - Psychiatry

Result continuities

  • Project

  • Continuities

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Others

  • Publication year

    2021

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    World Journal of Biological Psychiatry

  • ISSN

    1562-2975

  • e-ISSN

  • Volume of the periodical

    22

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    13

  • Pages from-to

    14-26

  • UT code for WoS article

    000519640300001

  • EID of the result in the Scopus database

    2-s2.0-85081726819